Double primary recurrent human epidermal growth factor receptor 2-positive breast cancer and esophageal cancer that responded well to chemotherapy
Crossref DOI link: https://doi.org/10.1007/s13691-018-0347-9
Published Online: 2018-10-01
Published Print: 2019-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yokoi, Shigehiro http://orcid.org/0000-0002-0470-0560
Maeda, Hiroyuki
Nishino, Takuma
Togawa, Tamotsu
Iida, Atsushi
Goi, Takanori
Text and Data Mining valid from 2018-10-01
Article History
Received: 26 March 2018
Accepted: 24 September 2018
First Online: 1 October 2018